Abdul-Aziz MH, Hammond NE, Brett SJ, Cotta MO, De Waele JJ, Devaux A, et al. Prolonged vs Intermittent Infusions of beta-Lactam Antibiotics in Adults With Sepsis or Septic Shock: A Systematic Review and Meta-Analysis. JAMA 2024.https://www.ncbi.nlm.nih.gov/pubmed/38864162
Averbuch D, Orasch C, Cordonnier C, Livermore DM, Mikulska M, Viscoli C, et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. Haematologica 2013;98(12):1826–35.https://www.ncbi.nlm.nih.gov/pubmed/24323983
Dulhunty JM, Brett SJ, De Waele JJ, Rajbhandari D, Billot L, Cotta MO, et al. Continuous vs Intermittent beta-Lactam Antibiotic Infusions in Critically Ill Patients With Sepsis: The BLING III Randomized Clinical Trial. JAMA 2024.https://www.ncbi.nlm.nih.gov/pubmed/38864155
Garcia-Vidal C, Cardozo-Espinola C, Puerta-Alcalde P, Marco F, Tellez A, Agüero D, et al. Risk factors for mortality in patients with acute leukemia and bloodstream infections in the era of multiresistance. PLoS One 2018;13(6):e0199531. https://www.ncbi.nlm.nih.gov/pubmed/29953464
Klastersky J, de Naurois J, Rolston K, Rapoport B, Maschmeyer G, Aapro M, et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Ann Oncol 2016;27(suppl 5):v111–v118.https://www.ncbi.nlm.nih.gov/pubmed/27664247
Morrissey CO, Gilroy NM, Macesic N, Walker P, Ananda-Rajah M, May M, et al. Consensus guidelines for the use of empiric and diagnostic-driven antifungal treatment strategies in haematological malignancy, 2014. Intern Med J 2014;44(12b):1298–314.https://www.ncbi.nlm.nih.gov/pubmed/25482742
Poon LM, Jin J, Chee YL, Ding Y, Lee YM, Chng WJ, et al. Risk factors for adverse outcomes and multidrug-resistant Gram-negative bacteraemia in haematology patients with febrile neutropenia in a Singaporean university hospital. Singapore Med J 2012;53(11):720–5.https://www.ncbi.nlm.nih.gov/pubmed/23192498
Tam CS, O'Reilly M, Andresen D, Lingaratnam S, Kelly A, Burbury K, et al. Use of empiric antimicrobial therapy in neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee. Intern Med J 2011;41(1b):90–101. https://www.ncbi.nlm.nih.gov/pubmed/21272173
Worth LJ, Lingaratnam S, Taylor A, Hayward AM, Morrissey S, Cooney J, et al. Use of risk stratification to guide ambulatory management of neutropenic fever. Australian Consensus Guidelines 2011 Steering Committee. Intern Med J 2011;41(1b):82–9. https://www.ncbi.nlm.nih.gov/pubmed/21272172
